Thermo Fisher, Phadia To Exit Allergy Test Antitrust Suit

By Melissa Daniels · January 5, 2018, 8:01 PM EST

A remote allergy service provider has agreed to drop antitrust claims against Phadia US Inc. and Thermo Fisher Scientific Inc. in a suit alleging Phadia partook in a conspiracy to restrict...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Stipulation of Dismissal

Case Information

Case Title

United Biologics, LLC v. American Academy of Allergy Asthma & Immunology, et al

Case Number

Court

Texas Western

Nature of Suit

Anti-Trust

Date Filed

January 13, 2014

Recent Articles By Melissa

March 08, 2018
Anthem Blue Cross, Health Net Violated FCA, 9th Circ. Told
February 15, 2018
Jury Awards Ex-UCLA Doctor $13M In Gender, Age Bias Trial
February 14, 2018
Ex-UCLA Doctor Seeks $16M As Gender Bias Trial Wraps
January 30, 2018
Ex-UCLA Oncologist Details Harassment In Gender Bias Trial
January 29, 2018
UnitedHealth Nears Nixing FCA Claims, But DOJ Row Not Over
January 16, 2018
9th Circ. Revives FCA Suit Against Ex-Lockheed Health Co.
January 12, 2018
Ex-Hospital Owner Gets Over 5 Years In Kickback Scheme
January 04, 2018
Judge Seeks Simplified Claims Process In Health Net Deal
November 06, 2017
Kimberly-Clark Says 'Bald Assertions' Can't Sustain FCA Suit
October 25, 2017
Maryland Hospital Sued By Patients Of Phony OB-GYN